Skip to main content

5 Result(s)

within Nooshin Hashemi-Sadraei Remove this filter English Remove this filter

and

  1. No Access

    Article

    The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC

    Concurrent chemotherapy and radiation therapy remains the standard-of-care treatment in patients with unresectable stage III non-small-cell lung cancer. Most regimens include low doses of radiosensitizing agen...

    Farhad Fakhrejahani, Nooshin Hashemi Sadraei, Tarek Mekhail in Current Oncology Reports (2013)

  2. No Access

    Article

    Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study

    Standard initial therapy for patients with pure and mixed anaplastic oligodendrogliomas (AO/MAO) includes chemotherapy and radiation therapy. Anaplastic oligodendrogliomas with 1p/19q co-deletion are more resp...

    Manmeet S. Ahluwalia, Hao **e, Saurabh Dahiya… in Journal of Neuro-Oncology (2015)

  3. No Access

    Article

    Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer

    Macroautophagy/autophagy is considered to play key roles in tumor cell evasion of therapy and establishment of metastases in breast cancer. High expression of LC3, a residual autophagy marker, in primary breas...

    Nooshin Hashemi-Sadraei, Gaëlle M. Müller-Greven… in Journal of Neuro-Oncology (2018)

  4. No Access

    Article

    Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis

    Concurrent chemoradiation (CRT) with a platinum-containing regimen is considered standard of care for eligible unresectable stage III non-small-cell lung cancer (NSCLC) patients. Attempts to improve locoregion...

    Vidhya Karivedu, Rishi Agarwal, Sulsal Ul Haque… in Journal of Radiation Oncology (2019)

  5. Article

    Open Access

    Spatial characterization and quantification of CD40 expression across cancer types

    CD40, a TNF receptor family member, is expressed by a variety of immune cells and is involved in the activation of both adaptive and innate immune responses. Here, we used quantitative immunofluorescence (QIF)...

    Katherine M. Bates, Ioannis Vathiotis, Tyler MacNeil, Fahad Shabbir Ahmed… in BMC Cancer (2023)

    Download PDF (3466 KB) View Article